Pharma's Almanac

Mobile Navigation

Subscribe for the Newsletter

Articles
Expert Interviews
Roundtable
Press Releases
Videos

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

inducible pluripotent stem cells, iPS

Sort By

1 / 1

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us
Nice Insight
That's Nice

Reach Our Team

Contact Us
Advertise

My Account

Login/Sign up

Site

Privacy Policy
Terms And Conditions

© 2025 PHARMA’S ALMANAC. All rights reserved.

1 / 1

Resetting the Biological Clock: OKSM and the Reversal of Aging

Aging

Resetting the Biological Clock: OKSM and the Reversal of Aging

David Alvaro, Ph.D.

Pharma's Almanac

PAO-25-30-22Mar 19, 2025

Scaling Cell and Gene Therapy Processes from R&D to Production

Cell and Gene Therapy

Scaling Cell and Gene Therapy Processes from R&D to Production

Shawn Bates; Antonio Fernandez-Perez, Ph.D.

Corning Life Sciences

PAO-12-23-CL-03Dec 12, 2023

Second Study with Induced Pluripotent Stem Cells is Approved in Japan

Stem Cells

Second Study with Induced Pluripotent Stem Cells is Approved in Japan

Emilie Branch

Pharma's Almanac

PAO-M02-19-NI-020Feb 21, 2019

Disease-In-A-Dish: Leveraging in vitro Human Models to Advance Drug Discovery

Drug Discovery

Disease-In-A-Dish: Leveraging in vitro Human Models to Advance Drug Discovery

Paul R. August; Mark J. Pincus, M.S.

Icagen

PAP-Q2-17-CL-006-5426Jun 05, 2017